Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors

Experimental Dermatology

Volumn 23, Issue 12, 2014, Pages 909-915

  Stoitzner, Patrizia ^a   Schaffenrath, Sandra ^a,b   Tripp, Christoph H ^a,b   Reider, Daniela ^a,b   Komenda, Kerstin ^a   Del Frari, Barbara ^a   Djedovic, Gabriel ^a   Ebner, Susanne ^a   Romani, Nikolaus ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Oncotyrol Center for Personalized Cancer Medicine   (Austria)

Author keywords

Dendritic cells; Immunotherapy; Langerhans cells; Skin

Indexed keywords

CD14 ANTIGEN; DEC 205; LANGERIN; LECTIN RECEPTOR; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; T6 ANTIGEN; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; ANTIGEN ANTIBODY COMPLEX; CD207 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; DEC-205 RECEPTOR; IMMUNOLOGICAL ADJUVANT; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; TLR3 PROTEIN, HUMAN;

ANTIGEN BINDING; ARTICLE; CELL MIGRATION; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; EX VIVO STUDY; EXPLANT; HUMAN; HUMAN CELL; IMMUNIZATION; PROTEIN EXPRESSION; PUNCH BIOPSY; SKIN BIOPSY; VACCINATION; ANTAGONISTS AND INHIBITORS; ANTIGEN ANTIBODY COMPLEX; CELL CULTURE; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; LANGERHANS CELL; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; CELLS, CULTURED; HUMANS; IMMUNIZATION; INJECTIONS, INTRADERMAL; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; POLY I-C; RECEPTORS, CELL SURFACE; RECEPTORS, MITOGEN; TOLL-LIKE RECEPTOR 3;

EID: 84913603813     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12573     Document Type: Article

References (58)

1. Palucka K, Banchereau J. Immunity 2013: 39: 38-48.
2. Vacchelli E, Vitale I, Eggermont A et al. Oncoimmunology 2013: 2: e25771.
3. Merad M, Ginhoux F, Collin M. Nat Rev Immunol 2008: 8: 935-947.
4. Romani N, Clausen B E, Stoitzner P. Immunol Rev 2010: 234: 120-141.
5. Collin M, McGovern N, Haniffa M. Immunology 2013: 140: 22-30.
6. Fehres C M, Garcia-Vallejo J J, Unger W W et al. Front Immunol 2013: 4: 157.
7. Klechevsky E, Banchereau J. Ann N Y Acad Sci 2013: 1284: 24-30.
8. Chu C C, Ali N, Karagiannis P et al. J Exp Med 2012: 209: 935-945.
9. Haniffa M, Shin A, Bigley V et al. Immunity 2012: 37: 60-73.
10. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Immunity 2000: 12: 71-81.
11. Ebner S, Ehammer Z, Holzmann S et al. Int Immunol 2004: 16: 877-887.
12. Carter R W, Thompson C, Reid D M et al. J Immunol 2006: 177: 2276-2284.
13. Tacken P J, de Vries I J, Torensma R et al. Nat Rev Immunol 2007: 7: 790-802.
14. Zaba L C, Krueger J G, Lowes M A. J Invest Dermatol 2009: 129: 302-308.
15. Caux C, Massacrier C, Vanbervliet B et al. Blood 1997: 90: 1458-1470.
16. Ratzinger G, Baggers J, de Cos M A et al. J Immunol 2004: 173: 2780-2791.
17. Klechevsky E, Morita R, Liu M et al. Immunity 2008: 29: 497-510.
18. Polak M E, Newell L, Taraban V Y et al. J Invest Dermatol 2012: 132: 1636-1644.
19. Schlitzer A, Ginhoux F. Curr Opin Immunol 2014: 26: 90-99.
20. Caminschi I, Maraskovsky E, Heath W R. Front Immunol 2012: 3: 13.
21. Romani N, Flacher V, Tripp C H et al. Curr Top Microbiol Immunol 2012: 351: 113-138.
22. Palucka K, Banchereau J. Nat Rev Cancer 2012: 12: 265-277.
23. Idoyaga J, Cheong C, Suda K et al. J Immunol 2008: 180: 3647-3650.
24. Flacher V, Tripp C H, Stoitzner P et al. J Invest Dermatol 2010: 130: 755-762.
25. Flacher V, Tripp C H, Haid B et al. J Immunol 2012: 188: 2146-2155.
26. Stoitzner P, Romani N, McLellan A D et al. Methods Mol Biol 2010: 595: 235-248.
27. Larsen C P, Steinman R M, Witmer-Pack M et al. J Exp Med 1990: 172: 1483-1493.
28. Stoitzner P, Zanella M, Ortner U et al. J Leukoc Biol 1999: 66: 462-470.
29. Haniffa M, Ginhoux F, Wang X N et al. J Exp Med 2009: 206: 371-385.
30. Oosterhoff D, Heusinkveld M, Lougheed S M et al. J Immunol 2013: 190: 3338-3345.
31. Mahnke K, Guo M, Lee S et al. J Cell Biol 2000: 151: 673-684.
32. Steinman R M. Annu Rev Immunol 2012: 30: 1-22.
33. Caskey M, Lefebvre F, Filali-Mouhim A et al. J Exp Med 2011: 208: 2357-2366.
34. Dhodapkar M V, Sznol M, Zhao B et al. Sci Transl Med 2014: 6: 232ra251.
35. Klechevsky E, Flamar A L, Cao Y et al. Blood 2010: 116: 1685-1697.
36. Igyarto B Z, Haley K, Ortner D et al. Immunity 2011: 35: 260-272.
37. Flacher V, Tripp C H, Mairhofer D G et al. EMBO Mol Med 2014: 6: 1191-1204.
38. Idoyaga J, Lubkin A, Fiorese C et al. Proc Natl Acad Sci USA 2011: 108: 2384-2389.
39. Idoyaga J, Fiorese C, Zbytnuik L et al. J Clin Invest 2013: 123: 844-854.
40. Gurer C, Strowig T, Brilot F et al. Blood 2008: 112: 1231-1239.
41. Birkholz K, Schwenkert M, Kellner C et al. Blood 2010: 116: 2277-2285.
42. Wang X N, McGovern N, Gunawan M et al. J Invest Dermatol 2014: 134: 965-974.
43. Jongbloed S L, Kassianos A J, McDonald K J et al. J Exp Med 2010: 207: 1247-1260.
44. Bachem A, Guttler S, Hartung E et al. J Exp Med 2010: 207: 1273-1281.
45. Lauterbach H, Bathke B, Gilles S et al. J Exp Med 2010: 207: 2703-2717.
46. Crozat K, Guiton R, Contreras V et al. J Exp Med 2010: 207: 1283-1292.
47. Cohn L, Chatterjee B, Esselborn F et al. J Exp Med 2013: 210: 1049-1063.
48. Meixlsperger S, Leung C S, Ramer P C et al. Blood 2013: 121: 5034-5044.
49. Voisin B, Mairhofer DG, Chen S et al. Exp Dermatol 2014: 23: 354-356.
50. Hawiger D, Inaba K, Dorsett Y et al. J Exp Med 2001: 194: 769-779.
51. Bonifaz L, Bonnyay D, Mahnke K et al. J Exp Med 2002: 196: 1627-1638.
52. Trumpfheller C, Caskey M, Nchinda G et al. Proc Natl Acad Sci USA 2008: 105: 2574-2579.
53. Furio L, Billard H, Valladeau J et al. J Invest Dermatol 2009: 129: 1963-1971.
54. Joffre O P, Sancho D, Zelenay S et al. Eur J Immunol 2010: 40: 1255-1265.
55. Mahnke K, Qian Y, Fondel S et al. Cancer Res 2005: 65: 7007-7012.
56. Johnson T S, Mahnke K, Storn V et al. Clin Cancer Res 2008: 14: 8169-8177.
57. Vasaturo A, Di Blasio S, Peeters D G et al. Front Immunol 2013: 4: 417.
58. Chen D S, Mellman I. Immunity 2013: 39: 1-10.